Browse studies

Find your next paid study

83 recruiting studies matching your filters

Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)

The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with oth…

Systemic SclerosisDiffuse Sclerosis SystemicInterstitial Lung Disease+1 more

Estimated

~$10 – $7,500

Paul SzabolcsNCT03630211

Phase 3

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with …

Pulmonary HypertensionInterstitial Lung Disease

Estimated

~$10 – $8,750

Insmed IncorporatedNCT07179380

Phase 3

A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease

The primary objective of this study is to evaluate the safety and tolerability of the long-term use of TPIP in participants with PH-ILD from Study INS1009-311 …

Pulmonary HypertensionInterstitial Lung Disease

Estimated

~$10 – $8,750

Insmed IncorporatedNCT07234032

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Interstitial Lung Disease Prospective Outcomes (IPF-PRO/ILD-PRO) Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibros…

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Estimated

~$10 – $750

Duke UniversityNCT01915511

Phase 2

A Phase 2A, Open-Label Single Arm Multicenter Exploratory Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Doses of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH).

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial L…

Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease

Estimated

~$10 – $8,750

AllRock Bio, Inc.NCT07175038

Respiratory, Limb Muscle Properties, and Physical Performance in Adult Lung Transplant Recipients

The goal of this observational study is to evaluate respiratory and limb muscle properties in adults awaiting lung transplantation and determine how these meas…

Lung TransplantationEnd Stage Lung Disease

Estimated

~$10 – $750

University of FloridaNCT07747337

Phase 1

Nucleoside Therapy in Patients With Telomere Biology Disorders

The goal of this clinical trial is to learn if a combination therapy of deoxycytidine (dC) plus deoxythymidine (dT) is safe in patients with telomere biology d…

Telomere Biology DisordersDyskeratosis CongenitaRevesz Syndrome+4 more

Estimated

~$10 – $8,750

Suneet AgarwalNCT06817590

Phase 2

A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 in Adults With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 in Adults with Pulmonary Hypertension …

Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Estimated

~$10 – $8,750

OrphAI TherapeuticsNCT05798923

Phase 2

Phase IIa Investigation of H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Background: Interstitial lung disease affects the tissues that aid the transfer of oxygen and carbon dioxide between the air and the bloodstream. The disease …

Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisLung Diseases, Interstitial

Estimated

~$10 – $5,625

National Institute of Environmental Health Sciences (NIEHS)NCT06325696

Observational

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. P…

Pulmonary HypertensionInterstitial Lung Disease

Estimated

~$10 – $6,250

University of RochesterNCT07561034

Observational

Impact of Ambulatory Oxygen Delivery on Real-world Activity and Quality-of-life in Patients With Interstitial Lung Disease (ILD) and Chronic Obstructive Pulmonary Disease (COPD)

Fibrotic forms of interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) are chronic lung disease which often affect how well oxygen …

Interstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia

Estimated

~$10 – $6,250

State University of New York at BuffaloNCT07512687

Observational

MOBoxy: MoblO2 to Maintain Oxygenation

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2…

COPD (Chronic Obstructive Pulmonary Disease)Intersitital Lung Disease

Estimated

~$10 – $7,500

Minnesota HealthSolutionsNCT07704567